Literature DB >> 32987208

Does expression of a human complement-regulatory protein on xenograft cells protect them from systemic complement activation?

Abhijit Jagdale1, Huy Nguyen1, Juan Li2, KaLia Burnette1, David Ayares3, David K C Cooper1, Hidetaka Hara4.   

Abstract

BACKGROUND: There are many causes of systemic complement activation, which may have detrimental effects on a pig xenograft. Transgenic expression of one or more human complement-regulatory proteins (hCRPs), e.g., hCD46, provides some protection to the xenograft, but it is not known whether it protects the xenograft from the effects of systemic complement activation. We used wild-type (WT) pig aortic endothelial cells (pAECs) to activate complement, and determined whether the expression of hCD46 on a1,3galactosyltransferase gene-knockout (GTKO) pAECs protected them from injury.
METHODS: CFSE-labeled and non-labeled pAECs from a WT, a GTKO, or a GTKO/hCD46 pig were separately incubated with heat-inactivated pooled human serum in vitro. Antibody pre-bonded CFSE-labeled and non-labeled pAECs were mixed, and then incubated with rabbit complement. The complement-dependent cytotoxicity was measured by flow cytometry.
RESULTS: There was significantly less lysis of GTKO/CD46 pAECs (6%) by 50% human serum compared to that of WT (91%, p<0.001) or GTKO (32%, p<0.01) pAECs. The lysis of GTKO pAECs was significantly increased when mixed with WT pAECs (p<0.05). In contrast, there was no significant change in cytotoxicity of GTKO/CD46 pAECs when mixed with WT pAECs.
CONCLUSIONS: The expression of hCD46 protected pAECs from systemic complement activation.
Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD46; Complement; Complement-regulatory protein; Pig; Xenotransplantation

Mesh:

Substances:

Year:  2020        PMID: 32987208      PMCID: PMC7686296          DOI: 10.1016/j.ijsu.2020.09.034

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  27 in total

1.  Consistent success in life-supporting porcine cardiac xenotransplantation.

Authors:  Matthias Längin; Tanja Mayr; Bruno Reichart; Sebastian Michel; Stefan Buchholz; Sonja Guethoff; Alexey Dashkevich; Andrea Baehr; Stefanie Egerer; Andreas Bauer; Maks Mihalj; Alessandro Panelli; Lara Issl; Jiawei Ying; Ann Kathrin Fresch; Ines Buttgereit; Maren Mokelke; Julia Radan; Fabian Werner; Isabelle Lutzmann; Stig Steen; Trygve Sjöberg; Audrius Paskevicius; Liao Qiuming; Riccardo Sfriso; Robert Rieben; Maik Dahlhoff; Barbara Kessler; Elisabeth Kemter; Mayuko Kurome; Valeri Zakhartchenko; Katharina Klett; Rabea Hinkel; Christian Kupatt; Almuth Falkenau; Simone Reu; Reinhard Ellgass; Rudolf Herzog; Uli Binder; Günter Wich; Arne Skerra; David Ayares; Alexander Kind; Uwe Schönmann; Franz-Josef Kaup; Christian Hagl; Eckhard Wolf; Nikolai Klymiuk; Paolo Brenner; Jan-Michael Abicht
Journal:  Nature       Date:  2018-12-05       Impact factor: 49.962

Review 2.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

3.  Involvement of both the classical and alternate pathways of complement in an ex vivo model of xenograft rejection.

Authors:  M Romanella; A Aminian; W R Adam; M J Pearse; A J d'Apice
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

Review 4.  The generation of transgenic pigs as potential organ donors for humans.

Authors:  E Cozzi; D J White
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

5.  Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins.

Authors:  L Genestier; S Fournel; M Flacher; O Assossou; J P Revillard; N Bonnefoy-Berard
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

6.  Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys.

Authors:  Gang Chen; Hua Qian; Thomas Starzl; Hongtao Sun; Bertha Garcia; Ximo Wang; Yishai Wise; Yuanqing Liu; Ying Xiang; Laura Copeman; Weihua Liu; Anthony Jevnikar; William Wall; David K C Cooper; Noriko Murase; Yifan Dai; Wanyu Wang; Yuliang Xiong; David J White; Robert Zhong
Journal:  Nat Med       Date:  2005-11-27       Impact factor: 53.440

7.  Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.

Authors:  Hayato Iwase; Hidetaka Hara; Mohamed Ezzelarab; Tao Li; Zhongqiang Zhang; Bingsi Gao; Hong Liu; Cassandra Long; Yi Wang; Amy Cassano; Edwin Klein; Carol Phelps; David Ayares; Abhinav Humar; Martin Wijkstrom; David K C Cooper
Journal:  Xenotransplantation       Date:  2017-03-17       Impact factor: 3.907

Review 8.  Recent investigations into pig antigen and anti-pig antibody expression.

Authors:  Guerard W Byrne; Christopher G A McGregor; Michael E Breimer
Journal:  Int J Surg       Date:  2015-08-22       Impact factor: 6.071

9.  Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.

Authors:  W L Fodor; B L Williams; L A Matis; J A Madri; S A Rollins; J W Knight; W Velander; S P Squinto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Marvin L Thomas Iii; Tannia Clark; Billeta G Lewis; Robert F Hoyt; Michael Eckhaus; Richard N Pierson Iii; Aaron J Belli; Eckhard Wolf; Nikolai Klymiuk; Carol Phelps; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  1 in total

Review 1.  Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function.

Authors:  Naomi Koehler; Leo Buhler; Bernhard Egger; Carmen Gonelle-Gispert
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-09       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.